Genomic characterization of plasmid-borne colistin resistance variants, mcr-1.1 and mcr-1.26, in multidrug-resistant Escherichia coli isolated from backyard farm animals
Colistin remains a high-priority, critically important antimicrobial that is used for treating severe infections caused by multidrug-resistant (MDR) Gram-negative bacteria. However, colistin resistance and the emergence of the mobile colistin resistance (mcr) genes have been increasingly documented...
محفوظ في:
| المؤلف الرئيسي: | Dina, Daaboul (author) |
|---|---|
| مؤلفون آخرون: | Kassem, Issmat I. (author), El Omari, Khaled (author), Eltai, Nahla O. (author), Hassan, Jouman (author), Al Jamal, Hadi (author), Fayad, Souad (author), Salma, Rayane (author), Ghorbani Tajani, Anahita (author), Bisha, Bledar (author), Hamze, Monzer (author), Oueslati, Saoussen (author), Cummings, Kevin J. (author), Dabboussi, Fouad (author), Naas, Thierry (author), Osman, Marwan (author) |
| التنسيق: | article |
| منشور في: |
2024
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://dx.doi.org/10.1016/j.jgar.2024.06.009 https://www.sciencedirect.com/science/article/pii/S2213716524001206 http://hdl.handle.net/10576/57489 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Plasmid-mediated colistin resistance encoded by mcr-1 gene in Escherichia coli co-carrying blaCTX-M-15 and blaNDM-1 genes in pediatric patients in Qatar
حسب: Tsui, Clement K. M.
منشور في: (2020) -
Seroprevalence of influenza A H1N1 and influenza D viruses in ruminants in Qatar
حسب: Hadeel T., Zedan
منشور في: (2025) -
Adipocyte Enhancer-Binding Protein 1 (AEBP1) (a Novel Macrophage Proinflammatory Mediator) Overexpression Promotes and Ablation Attenuates Atherosclerosis in ApoE⁻′⁻ and LDLR⁻′⁻ Mice
حسب: Bogachev, Oleg
منشور في: (2011) -
Efficacy and Safety of Colistin versus Tigecycline for Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Pathogens—A Meta-Analysis
حسب: Dina Abushanab (10696501)
منشور في: (2022) -
Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression
حسب: Afsheen Raza (492657)
منشور في: (2023)